Im Cannabis Corp   (IMCC)
Other Ticker:  
Price: $0.4604 $0.01 1.410%
Day's High: $0.4781 Week Perf: -5.38 %
Day's Low: $ 0.44 30 Day Perf: -35.15 %
Volume (M): 65 52 Wk High: $ 1.35
Volume (M$): $ 30 52 Wk Avg: $0.58
Open: $0.44 52 Wk Low: $0.19

 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 13
 Employees -
 Revenues (TTM) (Millions $) 37
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Im Cannabis Corp
IM Cannabis Corp is a global cannabis company with a focus on medical cannabis products and brands. They operate in multiple countries, including Israel, Germany, and Canada, leveraging their expertise in cultivation, distribution, and research to provide patients with safe and effective cannabis treatments. IM Cannabis Corp strives to be at the forefront of innovation in the industry, continuously developing new products and expanding their market presence to meet the growing demand for medical cannabis worldwide. They are committed to building a strong and sustainable business that promotes the well-being of their patients and the communities they serve.

   Company Address: 3606 ? 833 Seymour Street Vancouver 0 BC
   Company Phone Number:    Stock Exchange / Ticker: NASDAQ IMCC


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Im Cannabis Corp

IM Cannabis Corp Narrowing Losses and Surging Investor Interest in Q4 2023

In a stunning turn of events, Im Cannabis Corp (IMCC) has managed to navigate the challenging legal cannabis industry waters and significantly improve its financial results for the fiscal fourth quarter of 2023. While the company reported a loss, it's worth noting that IMCC managed to narrow its shortfall per share and improve revenue performance compared to previous periods. These developments have ignited strong investor interest, reflected in a notable surge in stock prices.
Financial Performance:
For the fiscal fourth quarter of 2023, IMCC reported a loss of $-0.57 per share, a substantial improvement compared to the previous year's staggering loss of $-20.67 per share. Sequentially, the company reported an upward trend, moving from $0.00 per share in the preceding financial reporting period. Additionally, IMCC witnessed a decline in revenue, although the decrease of -10.17% from $41.62 million to $37.38 million can be seen as commendable given the industry conditions.


Im Cannabis's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Im Cannabis does not provide revenue guidance.

Earnings Outlook
Im Cannabis Corp does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com